https://www.marketscreener.com/quote/stock/CAPRICOR-THERAPEUTICS-INC-59394636/news/Capricor-Therapeutics-Announces-Continuation-of-Phase-3-Hope-3-Trial-of-CAP-1002-in-Duchenne-Muscula-45548551/?utm_source=telegram&utm_medium=social&utm_campaign=share